dbACP: A Comprehensive Database of Anti-Cancer Peptides

8 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp05569 Piscidin-4 FIHHIIGGLFSAGKAIHRLIRRRRR Nile tilapia Necrosis Adenosine triphosphate (ATP) assay A549 Non-small cell Lung cancer (NSCLC) IC50 : 1.922 – 27.62 µM
dbacp05570 Piscidin-4 FIHHIIGGLFSAGKAIHRLIRRRRR Nile tilapia Necrosis Adenosine triphosphate (ATP) assay NCI-H661 Non-small cell Lung cancer (NSCLC) IC50 : 3.769 – 14.17 µM
dbacp05571 Piscidin-4 FIHHIIGGLFSAGKAIHRLIRRRRR Nile tilapia Necrosis Adenosine triphosphate (ATP) assay NCI-H1975 Non-small cell Lung cancer (NSCLC) IC50 : 1.241 – 5.472 µM
dbacp05572 Piscidin-4 FIHHIIGGLFSAGKAIHRLIRRRRR Nile tilapia Necrosis Adenosine triphosphate (ATP) assay HCC827 Non-small cell Lung cancer (NSCLC) IC50 :10.61 – 18.52 µM
dbacp06651 LUNA18 Not Available Synthetic Not available CellTiter-Glo Cell Viability assay NCI-H2122 NSCLC IC50 = 1.4 ± 0.3 nmol/L
dbacp06653 LUNA18 Not Available Synthetic Not available CellTiter-Glo Cell Viability assay NCI-H441 NSCLC IC50 = 2.9 ± 0.7 nmol/L
dbacp07018 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay H-358 Non Small Cell Lung Cancer (NSCLC) IC50 = 4.00 ± 0.20 μM
dbacp07019 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay H-1975 Non Small Cell Lung Cancer (NSCLC) IC50 between 4.0 and 5.5 μM